AndersenIM, KaszmarskaJ, McGrewSG. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol, 23:482–485. 2008.
2.
ChilcottLA, ShapiroCM. The socioeconomic impact of insomnia. Pharmacoeconomics, 10,Suppl. 1:1–14. 1996.
3.
DiddenR. Sleep Problems in Individuals with Developmental Disabilities. Assessment and Treatment. Boskoop: Drukkerij Macula, 2001.
4.
DodgeNN, WilsonGA. Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol, 16:581–584. 2001.
5.
GarstangJ, WallisM. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev, 32:585–589. 2006.
6.
GleasonMM, EggerHH, EmslieGJ, GreenhillLL. Psychopharmacological treatment for very young children; context and guidelines. J Am Acad Child Adolesc Psychiatry, 12:1532–1572. 2007.
7.
KalachnikJ. Benzodiazepine behavioral side effects: Review and implications for individuals with mental retardation. Am J Ment Retard, 107:376–410. 2002.
8.
KalachnikJE, HanzelTE, SevenichR, HarderSR. Brief report: Clonazepam behavioral side effects with an individual with mental retardation. J Autism Dev Disord, 33:349–354. 2003.
9.
MyamotoA, OkiJ, TakahashiS, OkunoA. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev, 21:59–62. 1999.
10.
PiazzaCC, FisherWW, KahngSW. Sleep patterns in children and young adults with mental retardation and severe behavior disorders. Dev Med Child Neurol, 38:335–344. 1996.
11.
RichdaleAL, FrancisA, GavidiaSG, CottonS. Stress, behavior and sleep problems in children with an intellectual disability. J Intellect Dev Disabil, 25:147–161. 1999.
SmitsMG, van StelHF, van der HeijdenK, MeijerAM, CoenenAML, KerkhofGA. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: A randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry, 42:1286–1293. 2003.
14.
StoresG. Children's sleep disorders: Modern approaches, developmental effects, and children at special risk. Dev Med Child Neurol, 41:568–573. 1999.
15.
TurkJ. Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: Short review and commentary. J Med Genet, 40:793–796. 2003.
16.
WrightB, SimsD, SmartS, AlwazeerA, Alderson-DayB, AllgarV, WhittonC, TomlinsonH, BennetS, JardineJ, McCaffreyN, LeylandC, JakemanC, MilesJ. Melatonin versus placebo in children with autism spectrum conditions, and severe sleep problems not amenable to behaviour management strategies; a randomized controlled crossover trial. J Autism Dev Disord, 41:175–184. 2011.
